1 – 10 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort
- Contribution to journal › Article
-
Mark
Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
- Contribution to journal › Article
-
Mark
Longitudinal association between sleep and Alzheimer's pathology
- Contribution to journal › Article
-
Mark
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
- Contribution to journal › Article
-
Mark
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers
- Contribution to journal › Article
-
Mark
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease : a prospective cohort study
- Contribution to journal › Article
- 2025
-
Mark
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals : implications for clinical trials
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease
- Contribution to journal › Article
